Pfizer Aktie News

Boomers today are between 60 and 79 years old.

Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.

Kenvue owns Johnson & Johnson's former over-the-counter brands. Medtronic has a diversified medical-device portfolio and is closing in on "Dividend King" status.

One is a pharmaceutical industry powerhouse that has fallen out of favor with investors. The other is a top REIT that cranks out a dividend far more often than the usual U.S. business.

Pfizer faces significant revenue headwinds from patent expiries, COVID product declines, and generic competition, but these risks are largely priced in. PFE's valuation is historically low at ~8x earnings, reflecting aggressive patent cliff assumptions and conservative growth projections for existing products. Pipeline and acquisition success, especially in obesity/diabetes, could drive capital...

Nine of fifteen Barron's Better Bets (BBB) 'safer' high-yield dividend stocks are currently attractively priced, including CAG, VZ, MO, BMY, TFC, UDR, KEY, KIM, and RF. Analyst forecasts project top-ten BBB Dogs could deliver average net gains of 26.33% by October 2026, with lower volatility than the overall market. ONEOK stands out as the only stock ranking in the top ten for yield, target, an...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Metsera, Inc. (NasdaqGS: MTSR) to Pfizer Inc. (NYSE: PFE). Under the terms of the proposed transaction, shareholders of Metsera will receive $47.50 per share in cash at closing, plus a non-transferable ...

Slow and steady performers do better over the long term.